NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

BNTC

Benitec Biopharma Inc

Apr 17 • 04:00PM ET

13.75

Dollar change +0.10
Percentage change 0.77	%

Healthcare • Biotechnology • USA • NASD

Peers: MRNA IONS ALNY CRSP ARWR NTLA SRPT EDIT SGMO QURE

| Held by: VXF PINK IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.97	Insider Own	6.46%	Shs Outstand	25.55M	Perf Week	15.16%
Market Cap	351.31M	Forward P/E	-	EPS next Y	-2.09	Insider Trans	173.68%	Shs Float	23.90M	Perf Month	-12.20%
Income	-22.03M	PEG	-	EPS next Q	-0.35	Inst Own	82.30%	Short Float	1.23%	Perf Quarter	24.32%
Sales	0.00M	P/S	-	EPS this Y	85.14%	Inst Trans	200.74%	Short Ratio	7.01	Perf Half Y	40.16%
Book/sh	3.24	P/B	4.25	EPS next Y	-134.17%	ROA	-42.65%	Short Interest	0.29M	Perf Year	187.66%
Cash/sh	3.07	P/C	4.48	EPS next 5Y	28.03%	ROE	-46.85%	52W Range	4.80 - 16.90	Perf YTD	8.87%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-29.01%	52W High	-18.64%	Beta	0.31
Dividend TTM	-	Quick Ratio	25.48	Sales past 5Y	-42.37%	Gross Margin	-	52W Low	186.46%	ATR (14)	1.20
Dividend Ex-Date	-	Current Ratio	25.48	EPS Y/Y TTM	72.73%	Oper. Margin	-	RSI (14)	55.16	Volatility	6.53% 11.15%
Employees	16	Debt/Eq	0.00	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	1.17	Target Price	27.17
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	87.37%	Payout	-	Rel Volume	0.79	Prev Close	13.65
Sales Surprise	-	EPS Surprise	57.46%	Sales Q/Q	-	Earnings	Feb 14 BMO	Avg Volume	41.95K	Price	13.75
SMA20	4.36%	SMA50	8.28%	SMA200	28.11%	Trades		Volume	33,112	Change	0.77%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-16-24	Initiated	H.C. Wainwright	Buy	$28
Dec-13-24	Initiated	Robert W. Baird	Outperform	$30
Oct-16-24	Initiated	Oppenheimer	Outperform	$35
Sep-12-24	Initiated	Guggenheim	Buy	$17
Jul-22-24	Initiated	Leerink Partners	Outperform	$13
Jun-13-24	Initiated	Piper Sandler	Overweight	$30
Oct-05-20	Downgrade	Ladenburg Thalmann	Buy → Neutral
Apr-20-20	Initiated	Ladenburg Thalmann	Buy	$14
Feb-26-16	Downgrade	Maxim Group	Buy → Hold
Dec-31-15	Reiterated	Maxim Group	Buy	$23 → $14
Sep-16-15	Reiterated	Maxim Group	Buy	$4 → $23

Show Previous Ratings

Apr-16-25 09:40AM	Are Medical Stocks Lagging Ascendis Pharma (ASND) This Year? (Zacks)
Apr-15-25 11:51PM	Benitec Biopharma: An Under-The-Radar And Undervalued Gene Therapy Developer (Seeking Alpha)
Mar-28-25 09:00AM	RNA Biotechs: Current State And Outlook (Seeking Alpha)
Mar-25-25 08:00AM	Benitec Biopharma Inc. Announces Pricing of $30 Million Common Stock Offering (GlobeNewswire)
Mar-19-25 07:00AM	Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated with BB-301 in Phase 1b/2a Study to be Presented at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference (GlobeNewswire)
07:00AM	Loading…
Feb-26-25 07:00AM	Benitec Biopharma to Participate in Upcoming Conferences in March (GlobeNewswire)
Feb-20-25 09:55AM	Wall Street Analysts Predict a 127.26% Upside in Benitec Biopharma (BNTC): Here's What You Should Know (Zacks)
Feb-14-25 08:10AM	Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update (GlobeNewswire) +15.98%
08:00AM	Benitec Biopharma Announces Acceptance of Late- Breaking Oral Abstract for the BB-301 Phase 1b/2a Clinical Study at the Muscular Dystrophy Association Clinical and Scientific Conference (GlobeNewswire)
Jan-27-25 08:00AM	Benitec Biopharma to Participate in Upcoming Conferences in January and February (GlobeNewswire)
Jan-13-25 09:49AM	Why You Shouldn't Bet Against Benitec Biopharma (BNTC) Stock (Zacks) -5.55%
Dec-17-24 06:25AM	Benitec Biopharma initiated with a Buy at H.C. Wainwright (TipRanks)
Dec-09-24 09:55AM	Wall Street Analysts See an 113.71% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High? (Zacks) +8.46%
08:50AM	Benitec Biopharma (BNTC) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
Nov-26-24 07:00AM	Benitec Biopharma to Participate in Upcoming Investor Conferences in December (GlobeNewswire)
04:30PM	Loading…
Nov-14-24 04:30PM	Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update (GlobeNewswire)
Nov-04-24 08:00AM	Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference (GlobeNewswire)
Oct-25-24 05:01PM	Janus Henderson Group PLC Expands Investment in Benitec Biopharma Inc (GuruFocus.com)
Oct-14-24 06:00AM	Benitec Biopharma Announces Updated Investor Webcast Information (GlobeNewswire) -6.45%
Oct-12-24 06:30AM	Benitec Biopharma Reports Positive Data from Two Subjects Treated with Low-Dose BB-301 in Phase 1b/2a Study Presented at 29th Annual Congress of the World Muscle Society (GlobeNewswire)
Sep-30-24 09:03PM	Suvretta Capital Management's Strategic Acquisition in Benitec Biopharma Inc (GuruFocus.com) +19.42%
Sep-26-24 04:30PM	Benitec Biopharma Releases Full Year 2024 Financial Results and Provides Operational Update (GlobeNewswire) +5.01%
Sep-18-24 08:00AM	Benitec Biopharma Announces Late Breaking Oral Abstract Presentation on BB-301 Phase 1b/2a Clinical Study at the 29th Annual Congress of the World Muscle Society (GlobeNewswire)
Sep-17-24 08:00AM	Benitec Biopharma CEO to Participate in OPMD Awareness Day Webinar (GlobeNewswire)
Jul-15-24 06:00AM	Benitec Biopharma Reports Continued Durable Improvements in the Radiographic Assessments of Swallowing Efficiency and the Subject-Reported Outcome Instrument at the 180-Day Timepoint for First OPMD Subject Treated with Low-Dose BB-301 in Phase 1b/2a Study (GlobeNewswire) +7.71%
Jul-01-24 07:00AM	Benitec Biopharma Announces Appointment of Kishen Mehta to its Board of Directors (GlobeNewswire)
May-13-24 02:53PM	BNTC Stock Earnings: Benitec Biopharma Misses EPS for Q3 2024 (InvestorPlace) -12.22%
08:15AM	Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update (GlobeNewswire)
May-01-24 08:00AM	Benitec Biopharma to Participate in the Citizens JMP Life Science Conference (GlobeNewswire) -6.51%
Apr-18-24 07:30AM	Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study (GlobeNewswire) +42.08%
07:00AM	Loading…
07:00AM	Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million (GlobeNewswire)
Apr-09-24 08:00AM	Benitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy on April 18, 2024 (GlobeNewswire)
Mar-24-24 07:55AM	11 Best ASX Stocks To Buy Now (Insider Monkey)
Feb-13-24 08:00AM	Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update (GlobeNewswire)
Nov-30-23 07:00AM	Benitec Biopharma Announces First Subject Dosed in Phase 1b/2a Clinical Trial for Gene Therapy Candidate BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy (GlobeNewswire)
Nov-17-23 08:00AM	Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire)
Nov-13-23 08:00AM	Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational Update (GlobeNewswire)
Sep-21-23 08:00AM	Benitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational Update (GlobeNewswire)
Aug-21-23 09:02PM	Citadel Advisors LLC Acquires New Stake in Benitec Biopharma Inc (GuruFocus.com)
Aug-18-23 09:02PM	JANUS HENDERSON GROUP PLC Acquires New Stake in Benitec Biopharma Inc (GuruFocus.com)
Aug-11-23 01:00PM	Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public Offering (GlobeNewswire)
Aug-08-23 10:30PM	Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering (GlobeNewswire) +65.80%
Jul-25-23 01:00PM	Benitec Biopharma Announces 1-for-17 Reverse Stock Split Effective July 26, 2023 (GlobeNewswire)
Jun-26-23 08:00AM	Benitec Biopharma Receives FDA Clearance of the IND for BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy (GlobeNewswire) +80.90%
May-15-23 08:00AM	Benitec Biopharma Releases Third Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire)
May-08-23 08:05AM	Benitec Biopharma to Present at the OPMD International Conference (GlobeNewswire)
08:00AM	Benitec Biopharma to Present at the JMP Securities Life Sciences Conference (GlobeNewswire)
Feb-13-23 08:00AM	Benitec Biopharma Releases Second Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire)
Jan-23-23 09:48AM	Benitec Biopharma Enrolls First OPMD Subject into the Clinical Development Program (GlobeNewswire) +9.08%
Nov-10-22 08:00AM	Benitec Biopharma Releases First Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire) +5.79%
Sep-16-22 08:42AM	Benitec Biopharma Inc. Announces Closing of $18 Million Underwritten Public Offering (GlobeNewswire) -15.43%
Sep-12-22 10:06PM	Benitec Biopharma Inc. Announces Pricing of $18 Million Underwritten Public Offering (GlobeNewswire) -6.63% -28.34%
Sep-02-22 08:00AM	Benitec Biopharma Releases Full Year 2022 Financial Results and Provides Operational Update (GlobeNewswire)
Jul-15-22 06:52AM	Having purchased US$827k worth of Benitec Biopharma Inc. (NASDAQ:BNTC) stock, the recent 11% pullback is not what insiders may have expected (Simply Wall St.) +7.00%
May-16-22 08:15AM	Benitec Biopharma Releases Q3 2022 Financial Results (GlobeNewswire) -8.79%
Feb-14-22 08:00AM	Benitec Biopharma Discloses Q2 2022 Financial Results (PR Newswire)
Jan-18-22 12:53PM	/C O R R E C T I O N from Source -- Norra Metals Corp./ (PR Newswire) -6.64%
Jan-17-22 09:30AM	Norra Metals Announces Private Placement Financing (PR Newswire)
Nov-27-21 06:54AM	We're Keeping An Eye On Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Rate (Simply Wall St.)
Nov-15-21 08:00AM	Benitec Biopharma Discloses Q1 2022 Financial Results (PR Newswire)
Sep-20-21 08:00AM	Benitec Biopharma Provides Operational Update and Releases its 2021 Fiscal Year-End Financial Results (PR Newswire) -7.86%
Sep-13-21 03:58PM	Benitec Biopharma to present at H.C. Wainwright's 23rd Annual Global Investment Conference (PR Newswire)
Sep-08-21 08:10AM	Benitec Biopharma Provides Overview of the BB-301 Phase 1b/2a Clinical Trial Design for 2022 (PR Newswire)
08:05AM	Benitec Biopharma Provides Positive Updates on the BB-301 Pilot Dosing Study in Large Animals (PR Newswire)
08:00AM	Benitec Biopharma Provides Positive Regulatory Updates for the BB-301 Development Program; BB-301 Phase 1b/2a Clinical Trial to Begin in 2022 (PR Newswire)
May-31-21 01:54AM	Is Benitec Biopharma (NASDAQ:BNTC) In A Good Position To Invest In Growth? (Simply Wall St.)
Apr-27-21 09:55PM	Benitec Biopharma Increases Previously Announced Bought Deal Offering of Common Stock to $12.9 Million (PR Newswire) -20.62%
04:44PM	Benitec Biopharma Announces $7.5 Million Bought Deal Offering of Common Stock (PR Newswire)
Mar-23-21 12:18PM	5 Top Stock Gainers for Tuesday: Dolphin Entertainment, Benitec (TheStreet.com) +190.28%
07:24AM	Tuesdays Pre-Market: Heres What You Need To Know Before The Market Opens (SmarterAnalyst)
07:09AM	Benitec Shares Skyrocket as Morgan Stanley Takes Stake (TheStreet.com)
Feb-24-21 09:26AM	Benitec Biopharma's Gene Therapy For Rare Muscle Disorder Shows Encouraging Action In Animal Studies (Benzinga) +5.60%
08:29AM	Benitec Biopharma Announces Successful Results from the Interim Analysis of the BB-301 Pilot Dosing Study (PR Newswire)
Dec-07-20 02:33PM	Benitec Biopharma Announces 2020 Annual Stockholder Meeting (PR Newswire)
Dec-02-20 12:06AM	A Quick Analysis On Benitec Biopharma's (NASDAQ:BNTC) CEO Compensation (Simply Wall St.)
Oct-06-20 04:05PM	Benitec Biopharma Announces Closing of $11.5 Million Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares (PR Newswire)
Oct-02-20 09:05AM	Benitec Biopharma Announces Pricing of $10.0 Million Public Offering (PR Newswire) -36.74%
Sep-23-20 04:54PM	Benitec Biopharma Provides Operational Update and Releases its 2020 Fiscal Year-End Financial Results (PR Newswire)
Sep-01-20 08:15AM	Benitec Biopharma to present at H.C. Wainwright's 22nd Annual Global Investment Conference (PR Newswire)
Jul-08-20 08:00AM	Benitec Biopharma Provides Update on BB-301 Tissue Transduction Study (PR Newswire)
Apr-20-20 06:49AM	Should You Be Concerned About Benitec Biopharma Limited's (NASDAQ:BNTC) Historical Volatility? (Simply Wall St.) +124.78%
Apr-15-20 08:52AM	Benitec Biopharma Announces the Completion of Redomiciliation to the United States (PR Newswire) -10.75%
Apr-14-20 09:28PM	Benitec Biopharma Appoints Edward Smith to the Board of Directors (PR Newswire) -10.31%
Mar-30-20 10:09AM	Benitec Announces Supreme Court of Queensland Approval for Redomicile (PR Newswire)
Mar-26-20 09:44AM	Benitec Announces Results of Scheme Meeting (PR Newswire) +7.60%
Feb-27-20 06:18PM	Is Benitec Biopharma (ASX:BLT) In A Good Position To Deliver On Growth Plans? (Simply Wall St.) +15.11%
Jan-31-20 08:08AM	Appendix 4C: Quarterly Cash Flow Report (PR Newswire) -6.73%
Nov-27-19 08:00AM	ASX/NASDAQ ANNOUNCEMENT: Re-domiciliation to the United States (PR Newswire) -10.17%
Nov-17-19 07:02PM	Some Benitec Biopharma (ASX:BLT) Shareholders Have Taken A Painful 93% Share Price Drop (Simply Wall St.)
Nov-15-19 07:00AM	Public consultation launched on global tailings dam standards (Reuters)
Oct-31-19 08:30AM	Appendix 4C: Quarterly Cash Flow Report (PR Newswire)
Sep-30-19 09:24AM	Benitec Biopharma Limited Announces US$2.25 Million Registered Direct Offering (PR Newswire) -15.24%
Sep-19-19 09:15AM	Benitec Biopharma to present at Ladenburg Thalmann 2019 Healthcare Conference (PR Newswire) -15.85%
Sep-16-19 08:00AM	Benitec Biopharma Provides Update on BB-301 Oculopharyngeal Muscular Dystrophy (OPMD) Program (PR Newswire)
Sep-15-19 09:49PM	Does Market Volatility Impact Benitec Biopharma Limited's (ASX:BLT) Share Price? (Simply Wall St.)
Jul-31-19 08:30AM	ASX/NASDAQ ANNOUNCEMENT Appendix 4C: Quarterly Cash Flow Report (PR Newswire) +28.79%
Jul-11-19 11:34PM	Could The Benitec Biopharma Limited (ASX:BLT) Ownership Structure Tell Us Something Useful? (Simply Wall St.)
Jun-06-19 08:09AM	Update on Oculopharyngeal Muscular Dystrophy Program (PR Newswire) -34.18%
May-08-19 08:01PM	Should Benitec Biopharma Limited (ASX:BLT) Be Your Next Stock Pick? (Simply Wall St.)
Mar-06-19 09:52PM	Introducing Benitec Biopharma, The Stock That Tanked 92% (Simply Wall St.)

Benitec Biopharma, Inc. is a development-stage biotechnology company, which engages in the advancement of novel genetic medicines. The firm's proprietary platforms include DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration. It is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy and Chronic Hepatitis B. The company was founded in 1995 and is headquartered in Hayward, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SUVRETTA CAPITAL MANAGEMENT, L	Director	Mar 31 '25	Buy	12.83	16,497	211,736	8,807,805	Apr 02 04:37 PM
SUVRETTA CAPITAL MANAGEMENT, L	Director	Mar 26 '25	Buy	13.00	900,000	11,700,000	8,793,245	Mar 28 04:51 PM
BUCHI J KEVIN	Director	Feb 27 '25	Option Exercise	3.86	51,813	199,998	103,910	Mar 03 02:20 PM
SUVRETTA CAPITAL MANAGEMENT, L	Director	Dec 23 '24	Buy	10.98	27,502	301,972	7,981,725	Dec 26 04:28 PM
SUVRETTA CAPITAL MANAGEMENT, L	Director	Dec 24 '24	Buy	11.25	20,018	225,202	7,999,455	Dec 26 04:28 PM
SUVRETTA CAPITAL MANAGEMENT, L	Director	Dec 03 '24	Buy	9.60	42,000	403,200	7,957,365	Dec 05 04:36 PM
SUVRETTA CAPITAL MANAGEMENT, L	Director	Nov 20 '24	Buy	10.22	27,436	280,396	7,920,175	Nov 21 04:24 PM
SUVRETTA CAPITAL MANAGEMENT, L	Director	Nov 19 '24	Buy	9.73	14,000	136,220	7,895,815	Nov 21 04:24 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BNTC

Benitec Biopharma Inc

Upgrade your FINVIZ experience